On the back of a strong quarter, Biocon boss Kiran Mazumdar-Shaw spoke exclusively to Business Today Televison's Abha Bakaya on the company's growth drivers among biosimilars and what the Union Budget needs to focus on as far as the healthcare sector is concerned.
On the back of a strong quarter, Biocon boss Kiran Mazumdar-Shaw spoke exclusively to Business Today Televison's Abha Bakaya on the company's growth drivers among biosimilars and what the Union Budget needs to focus on as far as the healthcare sector is concerned.
Experts expect the government to incentivise the private sector companies and high net-worth individuals (HNIs) to fund R&D in universities and research institutions among others.